Literature DB >> 3730054

Quantification and immunolocalization of apolipoprotein E in experimental atherosclerosis.

J J Badimon, B A Kottke, T C Chen, L Chan, S J Mao.   

Abstract

We developed a radioimmunoassay for rabbit apolipoprotein E (apo E) for studying their plasma apo E levels and its accumulation in the aorta of rabbits fed a cholesterol diet. Delipidation of plasma did not increase the apo E immunoreactivity and this immunoreactivity was indistinguishable from that in an apo E-phospholipid complex. The antigenic determinants of apo E in lipoprotein particles were therefore fully reacted with our goat anti-apo E antibodies. In our assay system, the non-ionic detergent Tween-20 was found to be necessary to significantly reduce the non-specific binding of 125I-labeled apo E to polystyrene tubes, and yet not interfere with the assay. In rabbits (n = 6) fed a high cholesterol (1%) diet, plasma apo E increased at least 10-fold above baseline levels and reached maximal levels within 17-20 days after the onset of cho-diet feeding. These levels were sharply reduced only 10 days after resuming a normal diet. Plasma total cholesterol levels went through a similar pattern. Thus, the plasma cholesterol concentration can simply be used to monitor the increase of apo E in cholesterol-fed rabbits. All the cholesterol-fed rabbits developed atherosclerotic fatty streak lesions and apo E located mostly in the thoracic region and was significantly correlated with the accumulation of lipids in the areas of lesion. In addition, the apo E deposition was limited to the aortic areas where lipids were present. On the other hand, apo A-I was not detectable in any lesion area. Our data suggest that apo E or apo E-containing lipoproteins, may be involved in the development of atherosclerosis in cholesterol-fed rabbits.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3730054     DOI: 10.1016/0021-9150(86)90113-9

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  2 in total

1.  Increased apolipoprotein E and c-fms gene expression without elevated interleukin 1 or 6 mRNA levels indicates selective activation of macrophage functions in advanced human atheroma.

Authors:  R N Salomon; R Underwood; M V Doyle; A Wang; P Libby
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

2.  Up-regulation of reverse cholesterol transport key players and rescue from global inflammation by ApoA-I(Milano).

Authors:  Giovanni Cimmino; Borja Ibanez; Gemma Vilahur; Walter S Speidl; Valentin Fuster; Lina Badimon; Juan J Badimon
Journal:  J Cell Mol Med       Date:  2008-12-16       Impact factor: 5.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.